Literature DB >> 6585811

Increased free cholesterol in plasma low and very low density lipoproteins in non-insulin-dependent diabetes mellitus: its role in the inhibition of cholesteryl ester transfer.

C J Fielding, G M Reaven, G Liu, P E Fielding.   

Abstract

Recombination of low and very low density lipoproteins (VLDL and LDL) from normal subjects with plasma from patients with non-insulin-dependent diabetes mellitus significantly increased the reduced rate of transfer of cholesteryl ester to these lipoproteins, which is characteristic of diabetic plasma, whereas diabetic VLDL and LDL reduced cholesteryl ester transfer rates in normal plasma. VLDL and LDL from diabetic plasma had an increased ratio of free cholesterol to phospholipid compared to normal, and unlike normal VLDL and LDL spontaneously lost free cholesterol to high density lipoprotein. These data suggest that the block to cholesteryl ester transfer to these lipoproteins in non-insulin-dependent diabetes is mediated by their increased free cholesterol content and may be related to the increased risk of these patients for developing atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6585811      PMCID: PMC345092          DOI: 10.1073/pnas.81.8.2512

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  25 in total

1.  Lipoprotein composition in diabetes mellitus.

Authors:  B V Howard; P J Savage; L J Bennion; P H Bennett
Journal:  Atherosclerosis       Date:  1978-06       Impact factor: 5.162

2.  The picomole determination of free and total cholesterol in cells in culture.

Authors:  J G Heider; R L Boyett
Journal:  J Lipid Res       Date:  1978-05       Impact factor: 5.922

3.  Apolipoprotein B levels and altered lipoprotein composition in diabetes.

Authors:  G Schonfeld; C Birge; J P Miller; G Kessler; J Santiago
Journal:  Diabetes       Date:  1974-10       Impact factor: 9.461

4.  Enzymatic determination of total serum cholesterol.

Authors:  C C Allain; L S Poon; C S Chan; W Richmond; P C Fu
Journal:  Clin Chem       Date:  1974-04       Impact factor: 8.327

5.  Human noninsulin-dependent diabetes: identification of a defect in plasma cholesterol transport normalized in vivo by insulin and in vitro by selective immunoadsorption of apolipoprotein E.

Authors:  C J Fielding; G M Reaven; P E Fielding
Journal:  Proc Natl Acad Sci U S A       Date:  1982-10       Impact factor: 11.205

6.  Promotion of sterol efflux and net transport by apolipoprotein E in lecithin:cholesterol acyltransferase deficiency.

Authors:  C J Fielding; J Frohlich; K Moser; P E Fielding
Journal:  Metabolism       Date:  1982-10       Impact factor: 8.694

7.  Characterization of human very low density lipoproteins containing two electrophoretic populations: double pre-beta lipoproteinemia and primary dysbetalipoproteinemia.

Authors:  A Pagnan; R J Havel; J P Kane; L Kotite
Journal:  J Lipid Res       Date:  1977-09       Impact factor: 5.922

8.  The interaction of heparin with an apoprotein of human very low density lipoprotein.

Authors:  F A Shelburne; S H Quarfordt
Journal:  J Clin Invest       Date:  1977-10       Impact factor: 14.808

9.  Regulation of human plasma lecithin:cholesterol acyltransferase activity by lipoprotein acceptor cholesteryl ester content.

Authors:  C J Fielding; P E Fielding
Journal:  J Biol Chem       Date:  1981-03-10       Impact factor: 5.157

10.  A cholesteryl ester transfer complex in human plasma.

Authors:  P E Fielding; C J Fielding
Journal:  Proc Natl Acad Sci U S A       Date:  1980-06       Impact factor: 11.205

View more
  13 in total

Review 1.  Interaction of lipid transfer protein with plasma lipoproteins and cell membranes.

Authors:  R E Morton
Journal:  Experientia       Date:  1990-06-15

Review 2.  Lipoprotein alterations in diabetes mellitus.

Authors:  G M Kostner; I Karádi
Journal:  Diabetologia       Date:  1988-10       Impact factor: 10.122

3.  Regulation of low-density lipoprotein particle size distribution in NIDDM and coronary disease: importance of serum triglycerides.

Authors:  S Lahdenperä; M Syvänne; J Kahri; M R Taskinen
Journal:  Diabetologia       Date:  1996-04       Impact factor: 10.122

4.  Plasma cholesterol metabolism in end-stage renal disease. Difference between treatment by hemodialysis or peritoneal dialysis.

Authors:  H Dieplinger; P Y Schoenfeld; C J Fielding
Journal:  J Clin Invest       Date:  1986-04       Impact factor: 14.808

5.  Effect of low density lipoprotein receptor deficiency on the metabolism of apolipoprotein B-100 in blood plasma. Kinetic studies in normal and Watanabe heritable hyperlipidemic rabbits.

Authors:  N Yamada; D M Shames; R J Havel
Journal:  J Clin Invest       Date:  1987-08       Impact factor: 14.808

6.  Increased cholesterylester transfer activity in complicated type 1 (insulin-dependent) diabetes mellitus--its relationship with serum lipids.

Authors:  R P Dullaart; J E Groener; L D Dikkeschei; D W Erkelens; H Doorenbos
Journal:  Diabetologia       Date:  1989-01       Impact factor: 10.122

7.  Regulation of hepatic very-low-density lipoprotein secretion in rats fed on a diet high in unsaturated fat.

Authors:  G F Gibbons; C R Pullinger
Journal:  Biochem J       Date:  1987-04-15       Impact factor: 3.857

Review 8.  Prevention of complications in non-insulin-dependent diabetes mellitus (NIDDM).

Authors:  B H Wolffenbuttel; T W van Haeften
Journal:  Drugs       Date:  1995-08       Impact factor: 9.546

9.  Short- and longer-term regulation of very-low-density lipoprotein secretion by insulin, dexamethasone and lipogenic substrates in cultured hepatocytes. A biphasic effect of insulin.

Authors:  S M Bartlett; G F Gibbons
Journal:  Biochem J       Date:  1988-01-01       Impact factor: 3.857

10.  Effects of postprandial lipemia on plasma cholesterol metabolism.

Authors:  G R Castro; C J Fielding
Journal:  J Clin Invest       Date:  1985-03       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.